Literature DB >> 30221161

Percutaneous ablation for HCC eligible to transplantation: providing more opportunities of remission in the context of graft shortage.

Jean-Charles Nault1,2,3, Pierre Nahon1,2,3, Olivier Séror2,3,4.   

Abstract

Year:  2018        PMID： 30221161      PMCID： PMC6131257          DOI： 10.21037/hbsn.2018.06.01

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  10 in total

1.  Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice?

Authors:  Tito Livraghi; Franca Meloni; Michele Di Stasi; Emanuela Rolle; Luigi Solbiati; Carmine Tinelli; Sandro Rossi
Journal:  Hepatology       Date:  2008-01       Impact factor: 17.425

2.  Histopathologic comparison of monopolar versus no-touch multipolar radiofrequency ablation to treat hepatocellular carcinoma within Milan criteria.

Authors:  Olivier Seror; Gisèle N'Kontchou; Jeanne Tran Van Nhieu; Yacine Rabahi; Pierre Nahon; Alexis Laurent; Jean Claude Trinchet; Daniel Cherqui; Eric Vicaut; Michel Beaugrand; Nicolas Sellier
Journal:  J Vasc Interv Radiol       Date:  2014-02-12       Impact factor: 3.464

3.  Survival after radiofrequency ablation and salvage transplantation in patients with hepatocellular carcinoma and Child-Pugh A cirrhosis.

Authors:  Gisèle N'Kontchou; Mounir Aout; Alexis Laurent; Pierre Nahon; Nathalie Ganne-Carrié; Véronique Grando; Iman Baghad; Dominique Roulot; Jean Claude Trinchet; Nicolas Sellier; Daniel Cherqui; Eric Vicaut; Michel Beaugrand; Olivier Seror
Journal:  J Hepatol       Date:  2011-05-19       Impact factor: 25.083

Review 4.  Percutaneous treatment of hepatocellular carcinoma: State of the art and innovations.

Authors:  Jean-Charles Nault; Olivier Sutter; Pierre Nahon; Nathalie Ganne-Carrié; Olivier Séror
Journal:  J Hepatol       Date:  2017-10-13       Impact factor: 25.083

5.  Radiofrequency ablation of hepatocellular carcinoma as bridge therapy to liver transplantation: A 10-year intention-to-treat analysis.

Authors:  Min Woo Lee; Steven S Raman; Nazanin H Asvadi; Surachate Siripongsakun; Robert M Hicks; Jeffrey Chen; Akeanong Worakitsitisatorn; Justin McWilliams; Myron J Tong; Richard S Finn; Vatche G Agopian; Ronald W Busuttil; David S K Lu
Journal:  Hepatology       Date:  2017-04-28       Impact factor: 17.425

6.  Early detection and curative treatment of hepatocellular carcinoma: A cost-effectiveness analysis in France and in the United States.

Authors:  Benjamin Cadier; Julie Bulsei; Pierre Nahon; Olivier Seror; Alexis Laurent; Isabelle Rosa; Richard Layese; Charlotte Costentin; Carole Cagnot; Isabelle Durand-Zaleski; Karine Chevreul
Journal:  Hepatology       Date:  2017-02-08       Impact factor: 17.425

7.  Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma.

Authors:  J M Llovet; R Vilana; C Brú; L Bianchi; J M Salmeron; L Boix; S Ganau; M Sala; M Pagès; C Ayuso; M Solé; J Rodés; J Bruix
Journal:  Hepatology       Date:  2001-05       Impact factor: 17.425

8.  Safety and Efficacy of Irreversible Electroporation for the Treatment of Hepatocellular Carcinoma Not Amenable to Thermal Ablation Techniques: A Retrospective Single-Center Case Series.

Authors:  Olivier Sutter; Joyce Calvo; Gisèle N'Kontchou; Jean-Charles Nault; Raffik Ourabia; Pierre Nahon; Nathalie Ganne-Carrié; Valérie Bourcier; Nora Zentar; Fatna Bouhafs; Nicolas Sellier; Abou Diallo; Olivier Seror
Journal:  Radiology       Date:  2017-04-28       Impact factor: 11.105

9.  Comparison of no-touch multi-bipolar vs. monopolar radiofrequency ablation for small HCC.

Authors:  Arnaud Hocquelet; Christophe Aubé; Agnès Rode; Victoire Cartier; Olivier Sutter; Anne Frederique Manichon; Jérome Boursier; Gisèle N'kontchou; Philippe Merle; Jean-Frédéric Blanc; Hervé Trillaud; Olivier Seror
Journal:  J Hepatol       Date:  2016-07-13       Impact factor: 25.083

10.  Transarterial chemoembolization for early stage hepatocellular carcinoma decrease local tumor control and overall survival compared to radiofrequency ablation.

Authors:  Arnaud Hocquelet; Olivier Seror; Jean-Frédéric Blanc; Nora Frulio; Cécile Salut; Jean-Charles Nault; Hervé Trillaud
Journal:  Oncotarget       Date:  2017-05-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.